STML - Stemline Therapeutics' (STML) CEO Ivan Bergstein on Q1 2019 Results - Earnings Call Transcript
Stemline Therapeutics, Inc (STML)
Q1 2019 Earnings Conference Call
May 10, 2019 8:00 AM ET
Company Participants
Ken Hoberman – Chief Operating Officer
Ivan Bergstein – Chief Executive Officer
Robert Francomano – Senior Vice President Global Head of Commercial
David Gionco – Chief Accounting Officer
Conference Call Participants
Jessica Fye – JP Morgan
Boris Peaker – Cowen
Matt Kaplan – Ladenburg Thalmann
Ram Selvaraju – Wainwright
Joe Catanzaro – Piper Jaffray
Jotin Marango – Roth Capital
Nathan Weinstein – Aegis Capital
Presentation
Operator
Good day, and welcome to the Stemline Earnings Conference Call. Today’s conference